EcoDrugPlus

Tachykinin Receptor 2

Ensembl ID : ENSPLAG00000012654
Gene Symbol: TACR2
3 Cross references
199 Possible Orthologues:

Tachykinin Receptor 3

Ensembl ID : ENSPLAG00000005184
Gene Symbol: TACR3
3 Cross references
208 Possible Orthologues:

Tachykinin Receptor 3-Like

Ensembl ID : ENSPLAG00000014836
Gene Symbol: TACR3L
2 Cross references
215 Possible Orthologues:

Target Of Rapamycin Complex Subunit Lst8

Ensembl ID : ENSPLAG00000012968
Gene Symbol: LOC106942740
3 Cross references
198 Possible Orthologues:

Telomerase Reverse Transcriptase

Ensembl ID : ENSPLAG00000019974
Gene Symbol: TERT
3 Cross references
189 Possible Orthologues:

Thromboxane A Synthase 1

Ensembl ID : ENSPLAG00000011364
Gene Symbol: TBXAS1
3 Cross references
219 Possible Orthologues:

Thromboxane A2 Receptor

Ensembl ID : ENSPLAG00000001554
Gene Symbol: TBXA2R
3 Cross references
192 Possible Orthologues:

Thymidine Phosphorylase

Ensembl ID : ENSPLAG00000012313
Gene Symbol: TYMP
4 Cross references
171 Possible Orthologues:

Thymidylate Synthetase

Ensembl ID : ENSPLAG00000021177
Gene Symbol: TYMS
3 Cross references
224 Possible Orthologues:

Thyrotropin Releasing Hormone Receptor

Ensembl ID : ENSPLAG00000009389
Gene Symbol: TRHR
1 Cross references
201 Possible Orthologues:

Thyrotropin-Releasing Hormone Receptor B

Ensembl ID : ENSPLAG00000016952
Gene Symbol: TRHRB
1 Cross references
193 Possible Orthologues:

Tissue Factor-Like

Ensembl ID : ENSPLAG00000019190
Gene Symbol: LOC106941476
2 Cross references
172 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).